No Data
J&J's (JNJ) Oral Pill Improves Depression & Insomnia Symptoms
Pfizer (PFE) Starts Another Cost-Cut Plan to Save $1.5B by 2027
Sector Update: Health Care
Health care stocks were mixed late Friday afternoon with the NYSE Health Care Index fractionally lower and the Health Care Select Sector SPDR Fund (XLV) adding 0.1%. The iShares Biotechnology ETF (IB
Marinus Completes Enrollment in Tuberous Sclerosis Complex Trial; Gets New Patent
Marinus Pharmaceuticals (MRNS) said Friday that it has completed enrollment in a phase 3 trial of oral ganaxolone for the treatment of seizures associated with tuberous sclerosis complex in children a
Here's Why Marinus Pharmaceuticals (MRNS) Is Poised for a Turnaround After Losing -7.8% in 4 Weeks
Buy Rating Affirmed: Marinus Pharmaceuticals' Advancements and Long-term Patent Protection Signal Strong Prospects
STD0313 : what is up with the huge drop from 10 to 1 dollar......MM making room for themselves? Did they file something late.....took a very quick scan and didn't see anything
TrytosaveabitOP STD0313: So this is how I see it! Bad earnings. Hedge funds shorting! Also when you have 50% of the daily volume going off exchange, it keeps a buying pressure of the board that would move price up. Take yesterday! Volume was just over 900K and damn close to 500K of that was routed off exchange! Kinda criminal IMO! There is over 5M shares sold short!